Xcout Intel
Metagen Therapeutics
Metagen Therapeutics, Inc. (MGTx) is a clinical-stage biotechnology company headquartered in Tsuruoka, Yamagata, Japan, with an additional office in Tokyo.
Subscribe to see Metagen Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Metagen Therapeutics at a glance
Metagen Therapeutics is a drug discovery and medical company headquartered in Japan. Its most recent funding round, Series A, raised $23.4M in February 2026. Xcout tracks 1 named person at Metagen Therapeutics, including Taku Nakahara (President and CEO).
Metagen Therapeutics leadership
- Taku NakaharaPresident and CEO
Metagen Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $23.4M | 4 named | |
| Series A | $12.2M | 4 named | |
| — | $1.7M | 4 named | |
| — | Undisclosed | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Metagen Therapeutics competitors
A few of Metagen Therapeutics's closest competitors — see the full list of competitors and alternatives →
SCOHIA PHARMA, Inc. is a clinical-stage specialty bioventure headquartered in Fujisawa, Japan. Established in 2017, the company focuses its research and development on lifestyle-related diseases including cardiovascular, metabolic, and renal disorders.
Mitsubishi Tanabe Pharma America is a research-based pharmaceutical company that delivers specialty medical treatments and health solutions in the United States. Headquartered in Jersey City, New Jersey, the privately held firm operates as part of a wider global pharmaceutical heritage.
Okogen, Inc. is a biotechnology research company headquartered in Plano, Texas, specializing in innovative eyecare solutions.
Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates from its base in Ibaraki, Japan.
Seren Bio Corp. is a clinical development-focused pharmaceutical company that licenses development candidates with confirmed proof of concept from other pharmaceutical companies. It utilizes a small team of experts to efficiently develop and commercialize these products at an early stage.
Get Metagen Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Metagen Therapeutics in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access